Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $678.07 billion, securing the top spot among global Pharmaceuticals companies. Novo Nordisk A/S (NOVO-B.CO) and Johnson & Johnson (JNJ) follow closely behind. The data was last updated on January 22, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
601
|
 Xilio Therapeutics
XLO
|
$40.69 M | $0.89 |
-0.87%
|
86.3%
|
United States
|
|
602
|
 SCYNEXIS
SCYX
|
$40.22 M | $1.06 |
13.1%
|
-40.4%
|
United States
|
|
603
|
 VYNE Therapeutics
VYNE
|
$40.12 M | $2.72 |
-9.1%
|
41.4%
|
United States
|
|
604
|
 MiNK Therapeutics
INKT
|
$40.03 M | $1.01 |
66.4%
|
-1.1%
|
United States
|
|
605
|
 CASI Pharmaceuticals
CASI
|
$39.97 M | $2.58 |
-7.1%
|
-51.7%
|
United States
|
|
606
|
 Atara Biotherapeutics
ATRA
|
$39.68 M | $6.89 |
-50.7%
|
-56.3%
|
United States
|
|
607
|
 Elevation Oncology
ELEV
|
$39.61 M | $0.67 |
26.1%
|
-72.4%
|
United States
|
|
608
|
 Tempest Therapeutics
TPST
|
$38.53 M | $0.88 |
8.1%
|
-76.6%
|
United States
|
|
609
|
 Intensity Therapeutics
INTS
|
$38.52 M | $2.55 |
43.3%
|
-41.5%
|
United States
|
|
610
|
 Precision BioSciences
DTIL
|
$38.13 M | $4.97 |
10.2%
|
-54.7%
|
United States
|
|
611
|
 AN2 Therapeutics
ANTX
|
$37.65 M | $1.26 |
-6.6%
|
-93.2%
|
United States
|
|
612
|
 Lumos Pharma
LUMO
|
$37.54 M | $4.34 |
0.00%
|
51.2%
|
United States
|
|
613
|
 Passage Bio
PASG
|
$36.81 M | $0.60 |
-7.8%
|
-31.9%
|
United States
|
|
614
|
 Kala Pharmaceuticals
KALA
|
$36.53 M | $7.69 |
16.2%
|
0.83%
|
United States
|
|
615
|
 Cadrenal Therapeutics
CVKD
|
$35.45 M | $19.89 |
17.8%
|
12.6%
|
United States
|
|
616
|
 Unity Biotechnology
UBX
|
$35.22 M | $2.09 |
73.0%
|
-1.1%
|
United States
|
|
617
|
 vTv Therapeutics
VTVT
|
$35.21 M | $13.48 |
1.3%
|
50.1%
|
United States
|
|
618
|
 Okyo Pharma
OKYO
|
$35.06 M | $1.04 |
20.7%
|
-20.7%
|
United Kingdom
|
|
619
|
 genOway Sa
ALGEN.PA
|
$34.79 M | $3.05 |
-20.3%
|
-30.2%
|
France
|
|
620
|
 LianBio
LIAN
|
$34.47 M | $0.24 |
-7.5%
|
46.6%
|
United States
|
|
621
|
 Acasti Pharma
ACST
|
$34.17 M | $3.71 |
3.1%
|
53.0%
|
Canada
|
|
622
|
 Herantis Pharma Oyj
HRTIS.HE
|
$34.01 M | $1.69 |
8.1%
|
7.7%
|
Finland
|
|
623
|
 Incannex Healthcare
IXHL
|
$33.26 M | $1.89 |
8.6%
|
-52.9%
|
Australia
|
|
624
|
 Eterna Therapeutics
ERNA
|
$32.63 M | $0.64 |
68.0%
|
-75.7%
|
United States
|
|
625
|
 Ocuphire Pharma
OCUP
|
$31.74 M | $1.04 |
0.00%
|
-61.9%
|
United States
|
|
626
|
 Pharma Equity Group A/S
PEG.CO
|
$30.23 M | $0.02 |
-2.8%
|
-55.3%
|
Denmark
|
|
627
|
 Cel-Sci
CVM
|
$30.14 M | $0.41 |
-42.9%
|
-84.9%
|
United States
|
|
628
|
 Marinus Pharmaceuticals
MRNS
|
$30.09 M | $0.55 |
110.1%
|
-94.6%
|
United States
|
|
629
|
 CytoMed Therapeutics
GDTC
|
$29.43 M | $2.55 |
-4.3%
|
-38.7%
|
Singapore
|
|
630
|
 BioAtla
BCAB
|
$28.93 M | $0.50 |
-20.6%
|
-74.8%
|
United States
|
|
631
|
 iBio
IBIO
|
$28.83 M | $3.07 |
16.9%
|
162.0%
|
United States
|
|
632
|
 Dare Bioscience
DARE
|
$28.54 M | $3.28 |
4.4%
|
-11.9%
|
United States
|
|
633
|
 Curis
CRIS
|
$27.69 M | $3.27 |
3.8%
|
-70.9%
|
United States
|
|
634
|
 Aelis Farma SA
AELIS.PA
|
$27.22 M | $2.00 |
-4.0%
|
-85.8%
|
France
|
|
635
|
 JanOne
JAN
|
$27.14 M | $2.18 |
0.00%
|
334.3%
|
United States
|
|
636
|
 Citius Pharmaceuticals
CTXR
|
$26.68 M | $3.15 |
5.4%
|
-80.4%
|
United States
|
|
637
|
 Advicenne S.A.
ALDVI.PA
|
$26.47 M | $2.16 |
4.0%
|
2.0%
|
France
|
|
638
|
 Omega Therapeutics
OMGA
|
$26.30 M | $0.47 |
-34.0%
|
-84.7%
|
United States
|
|
639
|
 Longeveron
LGVN
|
$25.52 M | $1.72 |
-3.4%
|
-80.3%
|
United States
|
|
640
|
 Sol-Gel Technologies
SLGL
|
$25.04 M | $0.90 |
-8.4%
|
-22.6%
|
Israel
|
|
641
|
 Lava Therapeutics
LVTX
|
$24.81 M | $0.94 |
-2.6%
|
-37.9%
|
Netherlands
|
|
642
|
 Valbiotis SA
ALVAL.PA
|
$24.13 M | $1.53 |
4.3%
|
-66.1%
|
France
|
|
643
|
 HOOKIPA Pharma
HOOK
|
$23.99 M | $1.99 |
2.9%
|
-72.1%
|
United States
|
|
644
|
 Lipocine
LPCN
|
$23.48 M | $4.39 |
-10.8%
|
17.8%
|
United States
|
|
645
|
 BioLineRx
BLRX
|
$23.47 M | $0.11 |
-52.2%
|
-92.0%
|
Israel
|
|
646
|
 Bullfrog AI
BFRG
|
$23.18 M | $2.66 |
-0.93%
|
-69.0%
|
United States
|
|
647
|
 Palatin Technologies
PTN
|
$22.52 M | $0.96 |
7.1%
|
-72.2%
|
United States
|
|
648
|
 Equillium
EQ
|
$22.32 M | $0.63 |
-1.5%
|
-13.5%
|
United States
|
|
649
|
 Pulmatrix
PULM
|
$22.32 M | $6.11 |
0.78%
|
220.6%
|
United States
|
|
650
|
 Nicox S.A.
ALCOX.PA
|
$21.88 M | $0.31 |
6.4%
|
-28.1%
|
France
|
|
651
|
 Cara Therapeutics
CARA
|
$21.85 M | $4.78 |
-16.5%
|
-32.0%
|
United States
|
|
652
|
 Aprea Therapeutics
APRE
|
$21.79 M | $4.01 |
22.6%
|
-31.3%
|
United States
|
|
653
|
 Athira Pharma
ATHA
|
$21.26 M | $0.55 |
-2.2%
|
-83.5%
|
United States
|
|
654
|
 Senti Biosciences
SNTI
|
$20.97 M | $4.57 |
12.0%
|
5.9%
|
United States
|
|
655
|
 Cocrystal Pharma
COCP
|
$20.35 M | $2.00 |
-21.4%
|
34.7%
|
United States
|
|
656
|
 ImmunoPrecise Antibodies
IPA
|
$20.02 M | $0.64 |
30.9%
|
-62.1%
|
United States
|
|
657
|
 Nfl Biosciences SAS
ALNFL.PA
|
$18.74 M | $1.95 |
1.2%
|
22.4%
|
France
|
|
658
|
 Carisma Therapeutics
CARM
|
$18.38 M | $0.44 |
10.5%
|
-81.4%
|
United States
|
|
659
|
 BioXcel Therapeutics
BTAI
|
$18.04 M | $0.36 |
-2.0%
|
-87.5%
|
United States
|
|
660
|
 Affimed
AFMD
|
$18.03 M | $1.10 |
-8.1%
|
-80.4%
|
Germany
|
|
661
|
 CervoMed
CRVO
|
$17.99 M | $2.18 |
-5.0%
|
-76.1%
|
United States
|
|
662
|
 Pieris Pharmaceuticals
PIRS
|
$17.96 M | $13.60 |
0.00%
|
1.6%
|
United States
|
|
663
|
 NanoViricides
NNVC
|
$17.07 M | $1.19 |
-21.2%
|
13.3%
|
United States
|
|
664
|
 Synlogic
SYBX
|
$16.73 M | $1.43 |
5.0%
|
-54.4%
|
United States
|
|
665
|
 GlycoMimetics
GLYC
|
$16.58 M | $0.26 |
8.3%
|
-92.6%
|
United States
|
|
666
|
 Ocean Biomedical
OCEA
|
$16.21 M | $0.47 |
-8.5%
|
-8.5%
|
United States
|
|
667
|
 Cingulate
CING
|
$16.16 M | $5.03 |
-2.1%
|
-88.9%
|
United States
|
|
668
|
 Spruce Biosciences
SPRB
|
$15.59 M | $0.38 |
-7.8%
|
-85.5%
|
United States
|
|
669
|
 Minerva Neurosciences
NERV
|
$14.76 M | $2.11 |
5.2%
|
-71.2%
|
United States
|
|
670
|
 Q-Interline A/S
QINTER.CO
|
$14.67 M | $0.81 |
-13.4%
|
-25.4%
|
Denmark
|
|
671
|
 AIM ImmunoTech
AIM
|
$14.35 M | $0.22 |
5.0%
|
-51.2%
|
United States
|
|
672
|
 Plant Advanced Technologies PAT SA
ALPAT.PA
|
$13.73 M | $12.29 |
0.85%
|
118.5%
|
France
|
|
673
|
 Valerio Therapeutics SA
ALVIO.PA
|
$13.60 M | $0.09 |
16.7%
|
-34.6%
|
France
|
|
674
|
 Imunon
IMNN
|
$12.91 M | $0.89 |
11.0%
|
54.2%
|
United States
|
|
675
|
 Aptose Biosciences
APTO
|
$12.72 M | $0.21 |
-12.0%
|
-88.4%
|
Canada
|
|
676
|
 Lyra Therapeutics
LYRA
|
$12.61 M | $0.19 |
11.0%
|
-96.1%
|
United States
|
|
677
|
 Talphera
TLPH
|
$12.17 M | $0.71 |
8.1%
|
-39.1%
|
United States
|
|
678
|
 BrainStorm Cell Therapeutics
BCLI
|
$12.15 M | $2.13 |
-15.2%
|
-60.6%
|
United States
|
|
679
|
 TherapeuticsMD
TXMD
|
$11.99 M | $1.04 |
-4.5%
|
-54.1%
|
United States
|
|
680
|
 Relmada Therapeutics
RLMD
|
$11.76 M | $0.39 |
3.6%
|
-89.1%
|
United States
|
|
681
|
 Oncodesign Precision Medicine Opm SA
ALOPM.PA
|
$11.73 M | $0.65 |
-19.5%
|
-67.5%
|
France
|
|
682
|
 Vinpai SAS
ALVIN.PA
|
$11.43 M | $3.43 |
2.8%
|
-39.6%
|
France
|
|
683
|
 Phio Pharmaceuticals
PHIO
|
$10.94 M | $2.29 |
25.9%
|
-54.7%
|
United States
|
|
684
|
 Ensysce Biosciences
ENSC
|
$10.80 M | $8.28 |
-22.1%
|
-62.7%
|
United States
|
|
685
|
 Aytu BioScience
AYTU
|
$10.58 M | $1.72 |
14.7%
|
-37.5%
|
United States
|
|
686
|
 Agile Therapeutics
AGRX
|
$10.43 M | $1.51 |
0.00%
|
4.1%
|
United States
|
|
687
|
 bioAffinity Technologies
BIAF
|
$10.36 M | $0.67 |
-28.9%
|
-56.5%
|
United States
|
|
688
|
 AEON Biopharma
AEON
|
$9.96 M | $0.12 |
-73.5%
|
-98.2%
|
United States
|
|
689
|
 Turnstone Biologics
TSBX
|
$9.95 M | $0.43 |
-2.9%
|
-84.8%
|
United States
|
|
690
|
 Jaguar Health
JAGX
|
$9.81 M | $0.83 |
-18.0%
|
-85.8%
|
United States
|
|
691
|
 Eagle Pharmaceuticals
EGRX
|
$9.72 M | $0.75 |
25.0%
|
-86.3%
|
United States
|
|
692
|
 Can Fite Biopharma
CANF
|
$9.48 M | $1.54 |
10.5%
|
-21.0%
|
Israel
|
|
693
|
 Hoth Therapeutics
HOTH
|
$9.39 M | $1.36 |
90.6%
|
17.2%
|
United States
|
|
694
|
 Addex Therapeutics
ADXN
|
$8.79 M | $7.70 |
-3.8%
|
5.3%
|
Switzerland
|
|
695
|
 Redhill Biopharma
RDHL
|
$8.44 M | $6.59 |
-0.31%
|
-71.6%
|
Israel
|
|
696
|
 Aptorum Group
APM
|
$8.00 M | $1.12 |
28.3%
|
-34.3%
|
Hong Kong
|
|
697
|
 Cyclerion Therapeutics
CYCN
|
$7.99 M | $2.95 |
-9.1%
|
-13.3%
|
United States
|
|
698
|
 Biofrontera
BFRI
|
$7.90 M | $1.02 |
8.9%
|
-33.7%
|
United States
|
|
699
|
 Mangoceuticals
MGRX
|
$7.53 M | $3.03 |
3.6%
|
-42.8%
|
United States
|
|
700
|
 TME Pharma NV
ALTME.PA
|
$7.30 M | $0.08 |
3.9%
|
-64.3%
|
Germany
|
|
701
|
 Orphazyme A/S
ORPHA.CO
|
$6.52 M | $156.28 |
0.00%
|
-12.7%
|
Denmark
|
|
702
|
 Xenetic Biosciences
XBIO
|
$6.66 M | $4.32 |
2.2%
|
20.8%
|
United States
|
|
703
|
 Viracta Therapeutics
VIRX
|
$6.48 M | $0.16 |
-32.0%
|
-65.3%
|
United States
|
|
704
|
 Genprex
GNPX
|
$6.40 M | $0.75 |
-22.4%
|
-92.1%
|
United States
|
|
705
|
 Evoke Pharma
EVOK
|
$6.39 M | $4.30 |
-10.2%
|
-41.8%
|
United States
|
|
706
|
 Adial Pharmaceuticals
ADIL
|
$6.24 M | $0.96 |
-8.6%
|
-24.4%
|
United States
|
|
707
|
 Eyenovia
EYEN
|
$6.18 M | $0.06 |
-26.7%
|
-96.2%
|
United States
|
|
708
|
 Soligenix
SNGX
|
$6.17 M | $2.46 |
-17.8%
|
-76.3%
|
United States
|
|
709
|
 Syros Pharmaceuticals
SYRS
|
$5.51 M | $0.21 |
7.9%
|
-96.6%
|
United States
|
|
710
|
 Organovo
ONVO
|
$5.49 M | $0.36 |
14.7%
|
-61.8%
|
United States
|
|
711
|
 AVROBIO
AVRO
|
$5.24 M | $1.40 |
0.00%
|
-100.0%
|
United States
|
|
712
|
 Quantum Genomics SA
ALQGC.PA
|
$5.23 M | $0.08 |
0.00%
|
-29.6%
|
France
|
|
713
|
 Bionomics
BNOX
|
$4.95 M | $3.24 |
-51.1%
|
-72.3%
|
Australia
|
|
714
|
 Quoin Pharmaceuticals
QNRX
|
$4.83 M | $0.59 |
17.7%
|
-85.4%
|
United States
|
|
715
|
 Galmed Pharmaceuticals
GLMD
|
$4.72 M | $2.85 |
-5.6%
|
-36.7%
|
Israel
|
|
716
|
 180 Life Sciences
ATNF
|
$4.67 M | $1.47 |
-46.2%
|
-61.1%
|
United States
|
|
717
|
 Portage Biotech
PRTG
|
$4.60 M | $4.10 |
-20.8%
|
-80.2%
|
|
|
718
|
 Theranexus SA
ALTHX.PA
|
$4.58 M | $0.57 |
-3.5%
|
-44.9%
|
France
|
|
719
|
Instituto Rosenbusch S.A.
ROSE.BA
|
$4.39 M | $0.10 |
-6.7%
|
36.2%
|
Argentina
|
|
720
|
 NuCana
NCNA
|
$4.36 M | $1.11 |
-4.6%
|
-85.2%
|
United Kingdom
|
|
721
|
 Gamida Cell
GMDA
|
$4.34 M | $0.03 |
0.00%
|
-94.6%
|
Israel
|
|
722
|
 MyMD Pharmaceuticals
MYMD
|
$4.31 M | $1.33 |
0.00%
|
-75.9%
|
United States
|
|
723
|
 Vincerx Pharma
VINC
|
$4.06 M | $0.11 |
-18.7%
|
-86.8%
|
United States
|
|
724
|
 Acticor Biotech SAS
ALACT.PA
|
$4.04 M | $0.26 |
0.00%
|
-94.9%
|
France
|
|
725
|
 Oragenics
OGEN
|
$3.90 M | $0.28 |
-26.3%
|
-94.6%
|
United States
|
|
726
|
 Tharimmune
THAR
|
$3.87 M | $2.00 |
-4.7%
|
-67.5%
|
United States
|
|
727
|
 Gritstone bio
GRTS
|
$3.80 M | $0.01 |
0.00%
|
-99.5%
|
United States
|
|
728
|
 Avalon GloboCare
ALBT
|
$3.72 M | $3.40 |
-10.7%
|
-37.6%
|
United States
|
|
729
|
 Sonoma Pharmaceuticals
SNOA
|
$3.48 M | $2.60 |
-2.9%
|
-22.1%
|
United States
|
|
730
|
 Lipella Pharmaceuticals
LIPO
|
$3.45 M | $2.85 |
-9.9%
|
-62.9%
|
United States
|
|
731
|
 Rua Bioscience Limited
RUA.NZ
|
$3.35 M | $0.02 |
-3.3%
|
-70.4%
|
New Zealand
|
|
732
|
 Azitra
AZTR
|
$3.33 M | $0.27 |
-39.5%
|
-99.4%
|
United States
|
|
733
|
 Biophytis S.A.
ALBPS.PA
|
$3.24 M | $0.31 |
-18.8%
|
-84.6%
|
France
|
|
734
|
 Vaccinex
VCNX
|
$3.24 M | $1.21 |
-3.6%
|
-86.0%
|
United States
|
|
735
|
 Titan Pharmaceuticals
TTNP
|
$3.11 M | $3.40 |
10.7%
|
-33.9%
|
United States
|
|
736
|
 Petros Pharmaceuticals
PTPI
|
$3.10 M | $0.31 |
4.2%
|
-76.0%
|
United States
|
|
737
|
 Matinas BioPharma
MTNB
|
$2.92 M | $0.57 |
8.1%
|
-94.4%
|
United States
|
|
738
|
 Talis Biomedical
TLIS
|
$2.86 M | $1.57 |
11.8%
|
-75.5%
|
United States
|
|
739
|
 Alaunos Therapeutics
TCRT
|
$2.74 M | $1.71 |
-8.2%
|
-90.8%
|
United States
|
|
740
|
 PainReform
PRFX
|
$2.69 M | $3.07 |
-32.7%
|
-76.3%
|
Israel
|
|
741
|
 Biora Therapeutics
BIOR
|
$2.53 M | $0.22 |
-53.2%
|
-97.7%
|
United States
|
|
742
|
 Medesis Pharma SA
ALMDP.PA
|
$2.02 M | $0.36 |
6.6%
|
-58.8%
|
France
|
|
743
|
 VBI Vaccines
VBIV
|
$1.87 M | $0.01 |
0.00%
|
-97.4%
|
United States
|
|
744
|
 Trevena
TRVN
|
$1.61 M | $1.86 |
3.3%
|
-88.9%
|
United States
|
|
745
|
 Advaxis
ADXS
|
$1.28 M | $0.03 |
0.00%
|
-95.4%
|
United States
|
|
746
|
 Altamira Therapeutics
CYTO
|
$1.13 M | $0.17 |
107.1%
|
-91.9%
|
|
|
747
|
 Evofem Biosciences
EVFM
|
$1.00 M | $0.01 |
11.1%
|
-69.7%
|
United States
|
|
748
|
 Hepion Pharmaceuticals
HEPA
|
$0.94 M | $0.14 |
-6.2%
|
-77.8%
|
United States
|
|
749
|
 Lucy Scientific Discovery
LSDI
|
$0.91 M | $0.02 |
0.00%
|
-99.0%
|
Canada
|
|
750
|
 PaxMedica
PXMD
|
$0.34 M | $0.03 |
-51.6%
|
-94.3%
|
United States
|
|
751
|
 Seelos Therapeutics
SEEL
|
$0.21 M | $0.02 |
-92.6%
|
-100.0%
|
United States
|
|
752
|
 Bellerophon Therapeutics
BLPH
|
$0.15 M | $0.01 |
-78.2%
|
-62.5%
|
United States
|
|
753
|
 Vaxxinity
VAXX
|
$0.06 M | $0.00 |
-20.0%
|
-99.9%
|
United States
|
|
754
|
 Neovacs SA
ALNEV.PA
|
$0.06 M | $0.53 |
-54.4%
|
-100.0%
|
France
|
|
755
|
 Ampio Pharmaceuticals
AMPE
|
$0.00 M | $0.00 |
0.00%
|
-99.8%
|
United States
|
|
756
|
 Pharnext SCA
ALPHA.PA
|
$0.00 M | $0.00 |
0.00%
|
-100.0%
|
France
|
|
757
|
 Calithera Biosciences
CALA
|
$0.00 M | $0.00 |
100.0%
|
-99.3%
|
United States
|
|
758
|
 eFFECTOR Therapeutics
EFTR
|
$0.00 M | $0.00 |
0.00%
|
-100.0%
|
United States
|
|
759
|
 Al Kout Industrial Projects Company K.S.C.P.
ALKOUT.KW
|
$0.00 M | $0.00 |
0.00%
|
0.00%
|
Kuwait
|